Par Drugs and Chemicals Limited
NSE:PAR.NS
187.57 (INR) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 366.539 | 222.43 | 162.064 | 211.638 | 73.792 | 0.306 | 0.637 | 0.184 | 9.295 |
| Short Term Investments
| 0.001 | 30.016 | 10.016 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 366.54 | 222.43 | 162.064 | 211.638 | 73.792 | 0.306 | 0.637 | 0.184 | 9.295 |
| Net Receivables
| 0 | 169.689 | 184.672 | 126.193 | 123.684 | 85.197 | 0 | 81.125 | 73.767 |
| Inventory
| 44.21 | 53.79 | 47.127 | 29.967 | 29.168 | 42.942 | 40.675 | 39.889 | 59.762 |
| Other Current Assets
| 47.396 | 83.956 | 33.919 | 35.123 | 18.433 | 14.277 | 11.382 | 8.502 | 3.325 |
| Total Current Assets
| 596.236 | 494.37 | 435.639 | 411.855 | 242.185 | 141.842 | 140.267 | 135.823 | 146.149 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 413.349 | 386.945 | 343.514 | 343.709 | 351.352 | 363.41 | 390.349 | 415.32 | 426.088 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | -0.7 | -1.2 | -1.407 | -1.259 | -1.64 | -3.477 | -8.484 | 0 |
| Long Term Investments
| 0.119 | 0.1 | 0.1 | 0.1 | 0.565 | 0.565 | 0.565 | 0.565 | 0.565 |
| Tax Assets
| 0 | 0.7 | 1.2 | 1.407 | 1.259 | 1.075 | 2.912 | 7.919 | 0 |
| Other Non-Current Assets
| 6.407 | 7.264 | 7.649 | 8.176 | 7.05 | 8.304 | 8.77 | 9.272 | 7.506 |
| Total Non-Current Assets
| 419.875 | 394.309 | 351.263 | 351.986 | 358.967 | 371.714 | 399.119 | 424.592 | 434.159 |
| Total Assets
| 1,016.111 | 888.679 | 786.902 | 763.841 | 601.152 | 513.555 | 539.389 | 560.414 | 580.308 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 53.562 | 80.915 | 106.618 | 67.178 | 62.045 | 49.318 | 52.613 | 77.831 | 64.354 |
| Short Term Debt
| 0 | 0 | 0 | 39.294 | 17.772 | 52.253 | 100.556 | 107.413 | 142.613 |
| Tax Payables
| 49.756 | 0 | 0 | 33.61 | 10 | 6.78 | 5.205 | 6.49 | 0 |
| Deferred Revenue
| 0 | 0.623 | 0.09 | 46.528 | 29.982 | 16.468 | 10.04 | 10.296 | 0 |
| Other Current Liabilities
| 21.073 | 58.979 | 41.956 | 19.71 | 22.292 | 12.23 | 8.326 | 6.03 | 12.914 |
| Total Current Liabilities
| 124.391 | 139.894 | 148.574 | 159.792 | 108.442 | 124.556 | 166.7 | 195.929 | 219.881 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0 | 0 | 43.917 | 46.191 | 60.314 | 130.695 | 143.008 | 164.884 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 47.853 | 50.053 | 3.269 | 2.633 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 35.4 | 35 | 35.5 | 34.051 | 36.512 | 34.243 | 32.372 | 27 | 0 |
| Other Non-Current Liabilities
| 0 | 1.402 | 4.056 | 37.986 | 40.374 | 37.513 | 0.003 | 29.444 | 21.986 |
| Total Non-Current Liabilities
| 35.4 | 36.402 | 39.556 | 81.903 | 86.565 | 97.826 | 165.703 | 172.452 | 186.87 |
| Total Liabilities
| 159.791 | 176.296 | 188.13 | 241.695 | 195.007 | 222.382 | 332.403 | 368.381 | 406.751 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 57.5 | 57.5 | 57.5 |
| Common Stock
| 123.046 | 123.046 | 123.046 | 61.523 | 61.523 | 44.803 | 27 | 27 | 27 |
| Retained Earnings
| 625.512 | 481.575 | 367.964 | 291.337 | 175.337 | 145.637 | 121.45 | 106.497 | 88.371 |
| Accumulated Other Comprehensive Income/Loss
| 1.036 | 1.036 | 1.036 | 1.036 | 1.036 | 1.036 | -57.5 | -57.5 | 0.686 |
| Other Total Stockholders Equity
| 106.726 | 106.726 | 106.726 | 168.249 | 168.249 | 99.697 | 0 | 0 | 0 |
| Total Shareholders Equity
| 856.32 | 712.383 | 598.772 | 522.145 | 406.145 | 291.173 | 206.986 | 192.033 | 173.557 |
| Total Equity
| 856.32 | 712.383 | 598.772 | 522.145 | 406.145 | 291.173 | 206.986 | 192.033 | 173.557 |
| Total Liabilities & Shareholders Equity
| 1,016.111 | 888.679 | 786.902 | 763.841 | 601.152 | 513.555 | 539.389 | 560.414 | 580.308 |